Dissemination, communication, engagement and exploitation

Workpackage #9

Dissemination, communication, engagement and exploitation

WP9 will focus on communicating the iCARE4CVD’s progress and results to
everyone that can benefit from our novel research. By facilitating effective
patient-engagement and two-way communication, WP9 provides a
platform for the patient voice within iCARE4CVD.

Through collecting patient feedback and aiding dialogue between patients
and the project, WP9 ensures we follow a patient-centric approach.
Moreover, we will develop a strategic communication and dissemination
plan that delivers tailored messages to all other key target audiences the
project aims to connect with, such as industry, health care professionals,
regulatory authorities, researchers, and citizens. In doing so, WP9 lays the
foundation for future exploitation of project outputs such as the federated
database and novel decision tools.

Meet our team

Roche

Valérie N. Babinsky

Clinical Development Lead

Catalyze

Carolina Vieira

Team Lead & Senio Science Communication Advisor
Kirsten Budig

Novo Nordisk

Kirsten Budig

Senior Public Affairs Manager

Roche

Ina Meyer

Global Patient Partnership Leader

Roche

Markus Schwertfeger , Dr med.

Senior International Director Medical Affairs
Get updated

Our related news

4 May, 2026

The Precision Moonshot: Redefining Cardiovascular Care for 85 Million Europeans

Cardiovascular disease affects 85 million Europeans, yet most patients are still treated..

30 April, 2026

The right treatment for the right patient: Rethinking heart failure care

Heart failure is a leading cause of hospitalisation in Europe, especially among..

29 April, 2026

“Suddenly, you are a patient 24 hours a day” – A patient perspective on living with heart failure

Heart failure affects millions worldwide, yet no two experiences are the same,..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.